Company
United StatesPublic company, NASDAQ: GILDGilead Sciences, Inc. (NASDAQ: GILD), Foster City, CA – FDA Inspections
Inspection records and compliance data for Gilead Sciences, Inc. in Foster City, California. 17 FDA inspections on record, 1 Form 483, last inspected January 16, 2026. Publicly traded as NASDAQ: GILD.
Company Profile
This profile covers Gilead Sciences, Inc. based in Foster City, California, United States.
FDA Inspection History
- FDA inspections
- 17
- OAI
- 0
- VAI
- 11
- NAI
- 5
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected December 4, 2009. Last inspected January 16, 2026.
Most cited issue areas
- Late submission of 15-day report2 inspections
- Electronic records1 inspection
- FDA access to sponsor records1 inspection
FDA inspections (17)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 16, 2026 | NAI | Human Drugs · Bioresearch Monitoring | 1300496 |
| January 29, 2025 | Not classified | Human Drugs | 1258330 |
| January 22, 2024 | VAI | Human Drugs · Bioresearch Monitoring | 1227801 |
| August 18, 2020 | NAI | Human Drugs · Bioresearch Monitoring | 1128174 |
| July 22, 2020 | VAI | Human Drugs · Bioresearch Monitoring | 1125580 |
| April 4, 2019 | NAI | Human Drugs · Drug Quality Assurance | 1086848 |
| July 17, 2018 | VAI | Human Drugs · Postmarket Surv. and Epidemiology | 1065316 |
| May 11, 2016 | VAI | Human Drugs · Bioresearch Monitoring | 975309 |
| April 14, 2016 | NAI | Human Drugs · Bioresearch Monitoring | 975181 |
| July 25, 2014 | VAI | Human Drugs · Drug Quality Assurance | 894003 |
| January 15, 2014 | VAI | Human Drugs · Bioresearch Monitoring | 861988 |
| October 9, 2013 | VAI | Human Drugs · Drug Quality Assurance | 852929 |
| April 26, 2013 | VAI | Human Drugs · Drug Quality Assurance | 830391 |
| June 26, 2012 | VAI | Human Drugs · Drug Quality Assurance | 787955 |
| October 18, 2011 | VAI | Human Drugs · Drug Quality Assurance | 749110 |
| June 14, 2010 | NAI | Human Drugs · Bioresearch Monitoring | 666168 |
| December 4, 2009 | VAI | Human Drugs · Drug Quality Assurance | 637652 |
FDA documents
People (5)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Gilead Sciences, Inc.
Stock ticker
GILD
Exchange
NASDAQ
Share price
$167.95
Market cap
$208.3B
Price as of
November 13, 2026
FEI Number
1000523075
Address
333 Lakeside Dr, Foster City, California 94404, United States
Country
United States
ID: 05c4ed0b-5c05-4c0e-996e-9e344fef905c